This presentation may contain forward-looking statements that are subject to risks and uncertainties, including those pertaining to the anticipated benefits to be realized from the proposals described herein. Forward-looking statements may include, in particular, statements about future events, future financial performance, plans, strategies, expectations, prospects, competitive environment, regulation, supply and demand. Esprinet has based these forward-looking statements on its view and assumptions with respect to future events and financial performance. Actual financial performance could differ materially from that projected in the forward-looking statements due to the inherent uncertainty of estimates, forecasts and projections, and financial performance may be better or worse

than anticipated. Given these uncertainties, readers should not put undue reliance on any forward-looking statements. The information contained in this presentation is subject to change without notice and Esprinet does not undertake any duty to update the forward-looking statements, and the estimates and the assumptions associated with them, except to the extent required by applicable laws and regulations.

(M/€)

(M/€)

31/12/2021

31/12/2020

Var. %

Q4 2021

Q4 2020

Var. %

Sales from contracts with customers

4,690.9

4,491.6

4%

Sales from contracts with customers

1,480.1

1,532.5

-3%

Gross Profit

232.9

194.5

20%

Gross Profit

67.1

65.8

2%

Gross Profit %

4.96%

4.33%

Gross Profit %

4.53%

4.29%

EBITDA adj.

86.1

69.1

25%

EBITDA adj.

28.3

27.5

3%

EBITDA adj. %

1.84%

1.54%

EBITDA adj. %

1.91%

1.79%

EBIT adj.

69.8

54.8

27%

EBIT adj.

24.1

23.9

1%

EBIT adj. %

1.49%

1.22%

EBIT adj. %

1.63%

1.56%

EBIT

68.4

47.6

44%

EBIT

23.5

20.1

17%

EBIT %

1.46%

1.06%

EBIT %

1.59%

1.31%

Net Income

44.1

31.8

39%

Net Income

15.5

14.3

8%

Net Income %

0.94%

0.71%

Net Income %

1.05%

0.93%

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Esprinet S.p.A. published this content on 08 March 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 31 March 2022 16:35:08 UTC.